The challenges of deliberate chemical/biological attack

Resuscitation

Volumn 58, Issue 3, 2003, Pages 293-296

  Lockey, David ^a   Davies, Gareth ^b  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Agents; Attacks; Challenges

Indexed keywords

BIOLOGICAL PRODUCT; CHEMICAL AGENT;

CLIMATE; EMERGENCY WARD; HEALTH CARE SYSTEM; HEALTH SERVICE; HOSPITAL CARE; HUMAN; INCIDENCE; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL PRACTICE; MEDICAL SPECIALIST; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; TREATMENT PLANNING; UNITED KINGDOM; VICTIM;

EID: 0041827205     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(03)00260-0     Document Type: Article

References (25)

1. Baker D.J. The immediate care of casualties following the release of toxic chemicals. Resuscitation. 42:1999;101-102.
2. Okumura T., Suzuki K., Fukuda A., Kohama A., Takasu N., Ishimatsu S., Hinohara S. The Tokyo subway Sarin attack: disaster management. Acad. Emerg. Med. 5:1998;613-624.
3. Thompson T.G. Preparing for bioterrorism. Anesthesiology. 97:(4):2002;776-777.
4. Public Health Laboratory Service. http://www.phls.co.uk.
5. Centre for Disease Control. http://www.cdc.gov.
6. Abraham R.B., Rudick V., Weinbroum A.A. Practical guidelines for acute care of victims of bioterrorism: conventional injuries and concomitant nerve agent intoxication. Anesthesiology. 97:(4):2002;989-1004.
7. White S.M. Chemical and biological weapons. Implications for anaesthesia and intensive care. Br. J. Anaesth. 89:(2):2002;306-324.
8. Sardesai A.M., Brown N.M., Menon D.K. Deliberate release of biological agents. Anaesthesia. 57:2002;1067-1082.
9. Geller R., Lopez G.P., Cutler S., Lin D., Bachman G.F., Gorman S.E. Atropine availability as an antidote for nerve agent casualties: validated rapid reformulation of high concentration atropine from bulk powder. Ann. Emerg. Med. 41:2003;453-456.
10. Kozak R.J., Siegal S., Kuzma J. Rapid atropine synthesis for the treatment of massive nerve agent exposure. Ann. Emerg. Med. 41:2003;685-688.
11. Martin C.O., Adamsjr H.P. Neurological aspects of biological and chemical terrorism: a review for neurologists. Arch. Neurol. 60:(1):2003;21-25.
12. Roffey R., Lantorp K., Tegnell A., Elgh F. Biological weapons and bioterrorism preparedness: importance of public-health awareness and international co-operation. Clin. Microbiol. Infect. 8:2002;522-528.
13. Wimbush S, Davies G, Lockey D. The presentation and management of victims of deliberate release of chemical and biological agents: A survey of knowledge among UK clinicians. Resuscitation.
14. Laurent J.F., Richter F., Michel A. Management of victims of urban chemical attack: the French approach. Resuscitation. 42:1999;141-149.
15. Department of Health. Pre hospital chemical and biological incident response. A briefing document. October 2001. ( http://www.doh.gov.uk ).
16. Moles T.M. Emergency medical services systems and HAZMAT major incidents. Resuscitation. 42:1999;103-116.
17. Cooper G. Nerve agents. J. R. Army Med. Corps. 148:2002;344-357.
18. Socher M.M. NBC Delta: special training beyond HAZMAT in the USA. Resuscitation. 42:1999;151-153.
19. Moles T.M., Baker D.J. Clinical analogies for the management of toxic trauma. Resuscitation. 42:1999;117-124.
20. Baker D.J. Advanced life support for toxic injuries (TOXALS). Eur. J. Emerg. Med. 3:(4):1996;327-348.
21. Advanced Life Support Group. UK SIMMS (Special Incident Medical Management and Support Course).
22. Han K.H., Walker R., Kuhri M. An integrated response to chemical incidents - the UK perspective. Resuscitation. 42:1999;133-140.
23. Crupi R.S., Asnis D.S., Lee C.C., Santucci T., Marino M.J., Flanz B.J. Meeting the challenge of bioterrorism: lessons learned from West Nile virus and anthrax. Am. J. Emerg. Med. 21:(1):2003;77-79.
24. Cone D.C., Weir S.D., Bogucki S. Convergent volunteerism. Ann. Emerg. Med. 41:2003;457-462.
25. Troop P. DCMO. Department of Health. http://www.doh.gov.uk/epcu/refdocs/dcmo14Mar02.doc.